Published in Clin Immunol on June 01, 1999
Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med (2002) 3.86
Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest (2009) 2.78
Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect Immun (2000) 2.63
Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect Immun (2005) 2.34
Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells. Infect Immun (2001) 1.88
Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection. J Immunol (2011) 1.56
Neutrophil-mediated mycobacteriocidal immunity in the lung during Mycobacterium bovis BCG infection in C57BL/6 mice. Infect Immun (2002) 1.52
Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: potential role of immature dendritic cells. Infect Immun (2005) 1.18
Comparison of interferon-γ-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection. Clin Exp Immunol (2012) 1.10
Mycobacterium bovis BCG vaccination augments interleukin-8 mRNA expression and protein production in guinea pig alveolar macrophages infected with Mycobacterium tuberculosis. Infect Immun (2002) 1.09
Rat neutrophils prevent the development of tuberculosis. Infect Immun (2004) 1.08
Efficacy of Mycobacterium indicus pranii immunotherapy as an adjunct to chemotherapy for tuberculosis and underlying immune responses in the lung. PLoS One (2012) 1.05
Guinea pig neutrophils infected with Mycobacterium tuberculosis produce cytokines which activate alveolar macrophages in noncontact cultures. Infect Immun (2007) 1.00
Early clearance of Mycobacterium tuberculosis: a new frontier in prevention. Immunology (2014) 0.98
A highly efficient Ziehl-Neelsen stain: identifying de novo intracellular Mycobacterium tuberculosis and improving detection of extracellular M. tuberculosis in cerebrospinal fluid. J Clin Microbiol (2012) 0.95
IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease. Int Immunol (2011) 0.86
Natural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection model. PLoS One (2012) 0.85
'"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection. BMC Med (2016) 0.82
Dynamics of immune effector mechanisms during infection with Mycobacterium avium in C57BL/6 mice. Immunology (2013) 0.80
Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity. J Transl Med (2017) 0.78
Inflammatory response to fine particulate air pollution exposure: neutrophil versus monocyte. PLoS One (2013) 0.78
Surface-exposed proteins of pathogenic mycobacteria and the role of cu-zn superoxide dismutase in macrophages and neutrophil survival. Proteome Sci (2013) 0.78
Partial deletion of argininosuccinate synthase protects from pyrazole plus lipopolysaccharide-induced liver injury by decreasing nitrosative stress. Am J Physiol Gastrointest Liver Physiol (2011) 0.77
The heterogenic properties of monocytes/macrophages and neutrophils in inflammatory response in diabetes. Life Sci (2014) 0.76
The Mycobacterium avium complex. Clin Microbiol Rev (1993) 7.67
Interaction of Mycobacterium avium with environmental amoebae enhances virulence. Infect Immun (1997) 3.14
Intracellular growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances virulence of Legionella pneumophila. Infect Immun (1999) 1.93
Legionella pneumophila entry gene rtxA is involved in virulence. Infect Immun (2001) 1.52
Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin. J Infect Dis (1987) 1.49
Phage infection, transfection and transformation of Mycobacterium avium complex and Mycobacterium paratuberculosis. Microbiology (1995) 1.31
Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials. Antimicrob Agents Chemother (2000) 1.29
Expression of the green fluorescent protein (GFP) in mycobacterium avium as a tool to study the interaction between Mycobacteria and host cells. Microb Pathog (1997) 1.21
Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection. Immunology (1995) 1.14
Differential gene expression in mononuclear phagocytes infected with pathogenic and non-pathogenic mycobacteria. Clin Exp Immunol (2004) 1.10
Interaction of Mycobacterium avium with human monocyte-derived dendritic cells. Infect Immun (2000) 1.10
Co-infection of macrophages modulates interferon gamma and tumor necrosis factor-induced activation against intracellular pathogens. J Exp Med (1990) 1.08
The white morphotype of Mycobacterium avium-intracellulare is common in infected humans and virulent in infection models. J Infect Dis (2001) 1.05
Mycobacterium avium invades the intestinal mucosa primarily by interacting with enterocytes. Infect Immun (2001) 1.04
Phenotypic consequences of red-white colony type variation in Mycobacterium avium. Microbiology (2001) 1.02
Roles of soluble fibronectin and beta 1 integrin receptors in the binding of Mycobacterium leprae to nasal epithelial cells. Clin Immunol Immunopathol (1993) 1.02
Mycobacterium avium enters intestinal epithelial cells through the apical membrane, but not by the basolateral surface, activates small GTPase Rho and, once within epithelial cells, expresses an invasive phenotype. Cell Microbiol (2000) 1.02
Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages. Antimicrob Agents Chemother (1994) 0.97
Mycobacterium avium infection of gut mucosa in mice associated with late inflammatory response and intestinal cell necrosis. J Med Microbiol (1998) 0.96
Response to stimulation with recombinant cytokines and synthesis of cytokines by murine intestinal macrophages infected with the Mycobacterium avium complex. Infect Immun (1995) 0.94
Mycobacterium avium resists exposure to the acidic conditions of the stomach. FEMS Microbiol Lett (2000) 0.92
Mycobacterium avium infection in mice is associated with time-related expression of Th1 and Th2 CD4+ T-lymphocyte response. Immunology (1997) 0.91
Invasion of the brain and chronic central nervous system infection after systemic Mycobacterium avium complex infection in mice. Infect Immun (2000) 0.91
Characterization and expression of secA in Mycobacterium avium. FEMS Microbiol Lett (2001) 0.89
Sequence and characterization of the glyceraldehyde-3-phosphate dehydrogenase of Mycobacterium avium: correlation with an epidermal growth factor binding protein. Microb Pathog (2000) 0.88
Mycobacterium avium infection of epithelial cells results in inhibition or delay in the release of interleukin-8 and RANTES. Infect Immun (1999) 0.87
Phenotypic and genomic analyses of the Mycobacterium avium complex reveal differences in gastrointestinal invasion and genomic composition. Infect Immun (2001) 0.86
Monoclonal antibodies for treatment of gram-negative infections. Rev Infect Dis (1990) 0.83
Mycobacterium avium complex in AIDS. Curr Clin Top Infect Dis (1992) 0.81
Mycobacterium avium reduces expression of costimulatory/adhesion molecules by human monocytes. Cell Immunol (1997) 0.81
Infection of mice with Mycobacterium avium primes CD8+ lymphocytes for apoptosis upon exposure to macrophages. Clin Immunol (2001) 0.79
The role of cytokines in mycobacterial infection. Biotherapy (1994) 0.78
Ultrastructural study of Mycobacterium avium infection of HT-29 human intestinal epithelial cells. J Med Microbiol (2000) 0.78
Imported ornamental fish are colonized with antibiotic-resistant bacteria. J Fish Dis (2013) 0.78
Interleukin-7 induces anti-Mycobacterium avium activity in human monocyte-derived macrophages. J Infect Dis (1996) 0.78
Perspective on animal models: chronic intracellular infections. Clin Infect Dis (2001) 0.78
Characterization of IS666, a newly described insertion element of Mycobacterium avium. Microb Comp Genomics (2000) 0.77
The VLA-4/VCAM-1 molecules participate in gamma delta cell interaction with endothelial cells. Cell Immunol (1992) 0.77
Immunomodulatory treatment of Mycobacterium avium complex bacteremia in patients with AIDS by use of recombinant granulocyte-macrophage colony-stimulating factor. J Infect Dis (1998) 0.77
Potential role of roxithromycin against the Mycobacterium avium complex. Infection (1995) 0.77
Mycobacterium avium ssp. hominissuis biofilm is composed of distinct phenotypes and influenced by the presence of antimicrobials. Clin Microbiol Infect (2011) 0.77
Mycobacterium avium interaction with macrophages and intestinal epithelial cells. Front Biosci (1999) 0.76
Cyclosporine and tacrolimus both suppress activation of Kupffer cells in vitro. Transplant Proc (1996) 0.76
Topical exposure to exogenous ultraviolet-irradiated urocanic acid enhances Mycobacterium ulcerans infection in a Crl:IAF(HA)-hrBR hairless guinea-pig model of Buruli ulcer disease. Photodermatol Photoimmunol Photomed (2004) 0.76
[Post-antibiotic effect in the treatment of infections in neutropenic patients]. Rev Hosp Clin Fac Med Sao Paulo (1987) 0.75
Practical issues in the antibiotic and immunotherapy of Mycobacterium avium disease in immunocompromised patients. Res Microbiol (1995) 0.75
[Effect of systemic antibiotic therapy on microbial flora of gastrointestinal tract in the hematological patients]. Rev Paul Med (1985) 0.75
The use of monoclonal antibodies in the diagnosis of partially treated Pseudomonas aeruginosa meningitis: patient report. Braz J Med Biol Res (1986) 0.75
[Use of monoclonal antibodies in the diagnosis and treatment of infection in immunocompromised patients]. Rev Paul Med (1989) 0.75
[Non-traumatic Clostridium infections]. AMB Rev Assoc Med Bras (1987) 0.75
[Bacteremias in immunosuppressed patients]. Rev Paul Med (1987) 0.75
Mycobacteria and AIDS: treatment, prevention and future prospects. Res Microbiol (1992) 0.75
Homologated aza analogs of arabinose as antimycobacterial agents. Bioorg Med Chem Lett (1998) 0.75